Skip to main content

Kristin

Analyst

Piper Sandler

Equibles does not estimate personal net worth.

About Kristin

Kristin is recorded as Analyst at Piper Sandler. Kristin has spoken on 2 earnings calls across 2 companies, most recently for UroGen Pharma Ltd. on November 4, 2026. Those appearances were for UroGen Pharma Ltd. (URGN) and Aquestive Therapeutics, Inc. (AQST). The companies whose calls Kristin spoke on are classified in the Healthcare sector.

Kristin on recent calls

“So what factors are the most important to drive acceleration as we move into years two and three of the launch of this jury? And what is most important when trying to broaden the number of unique prescribers?”
Analyst — Piper Sandler, UroGen Pharma Ltd. Q3 FY2026 Earnings Call ·
“A few questions from me, the first one, we've often talked about the product profile differences that will be important for payer discussions, but in your prepared remarks, you mentioned some of the clinical differentiation factors.”
Analyst, Aquestive Therapeutics, Inc. Q2 FY2026 Earnings Call ·

Affiliation history

  • Piper Sandler

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity